Malaria vaccine trial for healthy adults in Burkina Faso
Treatments studied
Part of Infections clinical trials.
This study tests a new malaria vaccine called PfSPZ-LARC2 in healthy adults. Participants will receive the vaccine and then be exposed to malaria to see if it protects them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You are in good general health
- You live in the study area in Burkina Faso for the whole study
- You are willing to take all study medications and follow the schedule
- You agree not to participate in other trials or donate blood during the study
- You are willing to get tested for HIV, hepatitis B, hepatitis C, and sickle cell trait
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new malaria vaccine called PfSPZ-LARC2 in healthy adults living in Burkina Faso. If you qualify, the vaccine is given to see if it can protect you from malaria.
This study tests an experimental malaria vaccine called PfSPZ-LARC2. Researchers want to learn if it is safe and effective for women who could become pregnant, especially in Mali where malaria is common. You would receive several doses of the vaccine and be followed for a few months.
This study tests an experimental malaria vaccine (CVD 36000) in healthy volunteers aged 18–50. Researchers will give you the vaccine and later expose you to malaria parasites in a controlled setting to see if the vaccine protects you. This helps develop a safer vaccine for people in malaria-prone countries.
This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.
This Phase 1/2 study tests a new vaccine meant to protect young children against malaria. If you qualify, your baby would get the study vaccine and be followed for about 12 months to check safety and early signs of protection.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
Hear when a new Malaria (Plasmodium Falciparum) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.